Tilak Mandadi - Aug 31, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Technology Officer
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Aug 31, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 04:48 PM
Previous filing
Jul 27, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (RSU) Award $0 +99.8K $0.00 99.8K Aug 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.